Can I read JAMA Oncology 2021 Phase II Radiochimio Et Immuno CBNPC on EtoBox?

JAMA Oncology 2021 Phase II Radiochimio Et Immuno CBNPC by supamancompany is a document available to read on EtoBox.

What is JAMA Oncology 2021 Phase II Radiochimio Et Immuno CBNPC about?

The Phase 2 KEYNOTE-799 trial evaluated the efficacy and safety of pembrolizumab combined with concurrent chemoradiation therapy (cCRT) in patients with unresectable, locally advanced, stage III non-small cell lung cancer (NSCLC). Results showed an objective response rate of approximately 70.5% in cohort A and 70.6% in cohort B, with manageable safety profiles, including grade 3 or higher pneumonitis occurring in 8.0% and 6.9% of patients, respectively. These findings suggest that pembrolizumab plus cCRT ma

Author

supamancompany

Language

EN